Cargando…
Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444229/ https://www.ncbi.nlm.nih.gov/pubmed/34539420 http://dx.doi.org/10.3389/fphar.2021.753231 |
| _version_ | 1784568446452760576 |
|---|---|
| author | Huang, Zhen Chen, Hui Wang, Shenglin Wei, Hongxiang Wang, Xinwen Shen, Rongkai Wang, Yunqing Lin, Rongjin Lin, Jianhua |
| author_facet | Huang, Zhen Chen, Hui Wang, Shenglin Wei, Hongxiang Wang, Xinwen Shen, Rongkai Wang, Yunqing Lin, Rongjin Lin, Jianhua |
| author_sort | Huang, Zhen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8444229 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84442292021-09-17 Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma Huang, Zhen Chen, Hui Wang, Shenglin Wei, Hongxiang Wang, Xinwen Shen, Rongkai Wang, Yunqing Lin, Rongjin Lin, Jianhua Front Pharmacol Pharmacology Frontiers Media S.A. 2021-09-02 /pmc/articles/PMC8444229/ /pubmed/34539420 http://dx.doi.org/10.3389/fphar.2021.753231 Text en Copyright © 2021 Huang, Chen, Wang, Wei, Wang, Shen, Wang, Lin and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Huang, Zhen Chen, Hui Wang, Shenglin Wei, Hongxiang Wang, Xinwen Shen, Rongkai Wang, Yunqing Lin, Rongjin Lin, Jianhua Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma |
| title | Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma |
| title_full | Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma |
| title_fullStr | Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma |
| title_full_unstemmed | Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma |
| title_short | Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma |
| title_sort | corrigendum: nlrp3 overexpression associated with poor prognosis and presented as an effective therapeutic target in osteosarcoma |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444229/ https://www.ncbi.nlm.nih.gov/pubmed/34539420 http://dx.doi.org/10.3389/fphar.2021.753231 |
| work_keys_str_mv | AT huangzhen corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT chenhui corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT wangshenglin corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT weihongxiang corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT wangxinwen corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT shenrongkai corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT wangyunqing corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT linrongjin corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma AT linjianhua corrigendumnlrp3overexpressionassociatedwithpoorprognosisandpresentedasaneffectivetherapeutictargetinosteosarcoma |